免疫系统
化学
多糖
对偶(语法数字)
细胞生物学
体液免疫
细胞免疫
免疫增强剂
细胞培养
佐剂
细胞免疫
生物化学
免疫学
细胞
抗体
抗原
药理学
免疫
生物活性
体外
脂多糖
作者
Jingwen Liu,Jian Wang,Yuancong He,Yaning Huang,Wenjing Quan,Huamei Mu,Junbo Gou,Xiaozhi Peng
标识
DOI:10.1021/acs.molpharmaceut.6c00283
摘要
Adjuvants are indispensable for subunit vaccines. However, the development of safe and effective adjuvants remains a major challenge. Polysaccharides derived from traditional Chinese medicine (TCM) have recently emerged as promising sources of novel vaccine adjuvants. In this study, we investigated the adjuvant activity of Polygonatum sibiricum polysaccharide (PSP) in combination with the glycolipid α-galactosylceramide (αGalCer or αGC). In vitro, PSP significantly promoted the activation of RAW264.7 and DC2.4 cells. In vivo, the PSP/αGC dual adjuvant group elicited markedly stronger cytokine production and a more robust humoral immune response compared with the single adjuvant groups. Moreover, it induced a strong cellular immune response with a balanced Th1/Th2 response and enhanced memory T-cell responses. The dual-adjuvant system also demonstrated a good biocompatibility and safety in mice. To our knowledge, this is the first report of a dual-adjuvant system combining a plant-derived polysaccharide with an iNKT cell agonist, highlighting PSP/αGC as a promising platform for next-generation vaccine design.
科研通智能强力驱动
Strongly Powered by AbleSci AI